Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation


You May Also Like

BioNTech Appoints Dr. Özlem Türeci as Chief Medical Officer

MAINZ, Germany, May 29, 2018 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company ...

Colgate-Palmolive and Klox Technologies Enter Into Agreements for Oral Health

NEW YORK and LAVAL, Quebec, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Colgate-Palmolive Company ("Colgate") ...